The largest database of trusted experimental protocols

Scopolamine methyl nitrate

Manufactured by Merck Group
Sourced in United States, Sao Tome and Principe, Germany

Scopolamine methyl nitrate is a chemical compound used in various laboratory applications. It is a salt formed by the reaction of scopolamine, a naturally occurring alkaloid, with nitric acid. This product is commonly used as a research tool in scientific experiments and analysis. Its core function is to serve as a reagent or analytical standard in controlled laboratory settings.

Automatically generated - may contain errors

31 protocols using scopolamine methyl nitrate

1

Pilocarpine-Induced Seizure Model in Mice and Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
As described previously41 (link), adult male C57Bl/6-N mice received a low dose of scopolamine methyl nitrate (1 mg kg−1, subcutaneous (s.c.); Sigma) 20 min before the administration of pilocarpine hydrochloride (335 mg kg−1, s.c.; Sigma). Forty minutes after SE onset, the mice received 4 mg kg−1 s.c. diazepam (Ratiopharm). Sham-control animals were treated identically, but received saline instead of pilocarpine.
Adult male Sabra rats (150–200 g) were kept in the animal facility of Hebrew University and Hadassah School of Medicine. All the experiments were approved by the local institution's ethical committee. Rats were injected with scopolamine methyl nitrate (1 mg kg−1, s.c; Sigma). Thirty minutes afterwards, SE was induced with a single dose of pilocarpine (350 mg kg−1 (i.p.); Sigma). SE was terminated after 2 h by diazepam (Ratiopharm; 0.1 mg kg−1 (i.p.)).
+ Open protocol
+ Expand
2

Pharmacological Agents in Neuronal Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Picrotoxin, pilocarpine, scopolamine methyl nitrate and pentobarbital were purchased from Sigma-Aldrich (St. Louis, MO, USA), Lactec D from Otsuka Pharmaceutical Factory (Tokushima, Japan), TTX from Sankyo (Osaka, Japan), D-APV and CNQX from Tocris Bioscience (Avonmouth, U.K.) and halothane from Takeda Pharmaceutical Company Limited (Osaka, Japan).
+ Open protocol
+ Expand
3

Pilocarpine-Induced Status Epilepticus in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male C57BL/6 mice 7–8 weeks of age were administered scopolamine methyl nitrate (intraperitoneally (i.p.); 1.5 mg/kg; Sigma-Aldrich) and terbutaline hemisulfate salt (i.p.; 1.5 mg/kg; Sigma-Aldrich) to block peripheral effects of PI and dilate the respiratory tract, respectively. PI hydrochloride (i.p.; Sigma-Aldrich) at 320 mg/kg was injected 30 min later (Fig. 1E). After continuous tonic clonic convulsive seizures were initiated, mice were placed at room temperature for 8 h and monitored with video recoding. Acute seizures were behaviorally scored using a modified Racine scale (Additional file 1: Videos S1–S6, stages: 0, no abnormality; 1, exploring, sniffing, and grooming ceased, becoming motionless; 2, forelimb and/or tail extension, appearance of rigid posture; 3, myoclonic jerks of the head and neck, with brief twitching movement, or repetitive movements with head bobbing; 4, forelimb clonus and partial rearing, or occasional rearing and falling; 5, forelimb clonus, continuous rearing and falling; and 6, tonic–clonic movements with loss of posture tone, often resulting in death) [27 (link)–29 (link)]. Only mice showing multiple stage 5 or above behavioral seizures were selected for further processing as status epilepticus.
+ Open protocol
+ Expand
4

Rat Oxidative Stress and Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pilocarpine (Sigma Aldrich, Hamburg, Germany); diazepam (Sopharma, Sofia, Bulgaria); scopolamine methyl nitrate (Sigma Aldrich, Hamburg, Germany); phenazine methosulfate (PMS), nitroblue tetrazolium (NBT), trichloroacetic acid (TCA), thiobarbituric acid (TBA), 5,5′-dithio-bis-(2-nitrobenzoic acid) (DTNB); TNF-α Rat ELISA Kit-Invitrogen-Thermo Fisher Scientific, Vienna, Austria, and IL-1β Rat ELISA Kit-Invitrogen-Thermo Fisher Scientific, Vienna, Austria.
+ Open protocol
+ Expand
5

Pilocarpine-induced Seizure Model in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pilocarpine hydrochloride and scopolamine methyl nitrate were purchased from Sigma-Aldrich (St Louis, MO, United States). From PND35 to PND55, L9 and L15 rats received a single daily intraperitoneal injection of pilocarpine (45 mg/kg/day dissolved in saline; n = 9 L9 and 9 L15 rats), as previously described (Guedes and Vasconcelos, 2008 (link)), or vehicle (saline; n = 9 L9 and 9 L15 rats). One additional L9 and one L15 group received no treatment (naïve groups; n = 9 L9 and 9 L15 rats). scopolamine methyl nitrate, a muscarinic receptor antagonist, was administered i.p., (1 mg/kg/day dissolved in 0.9% saline) in both groups 30 min before pilocarpine or saline administration to prevent the peripheral cholinergic effects elicited by pilocarpine (Peixinho-Pena et al., 2012 (link)). Immediately following pilocarpine administration, the animals were observed over 1 h for detection of spontaneous seizures as measured by the Racine (1972) (link) scale with the following stages: (0) No abnormality; (1) Mouth and facial movements; (2) Head nodding; (3) Forelimb clonus; (4) Rearing with forelimb clonus; (5) Rearing and falling with forelimb clonus. At this low dose of pilocarpine, no behavioral signs of epilepsy were detected in our animals.
+ Open protocol
+ Expand
6

Pilocarpine-Induced Seizure Model in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
To induce SE, pilocarpine hydrochloride, a muscarinic cholinergic agonist (Sigma; 360 mg/kg) was injected to animals Intraperitoneally (IP). Animals were pretreated with cholinergic antagonist, scopolamine methyl nitrate (Sigma; 1 mg/kg IP) 30 minutes before pilocarpine injection to reduce the peripheral cholinergic effects (Ferhat et al., 2003 (link)).
The behavior of the rats was observed for several hours after injection, and scored using the Racine classification (Racine, 1972 (link)). Only rats that displayed SE (stages 3–5) for 3–4 hours were selected in the current study. To finish seizures, diazepam (7 mg/kg, IP) was injected to the rats. Animals were hand fed after SE until they could eat and drink. After two weeks from the first spontaneous recurrent limbic seizures, the occurrence of spontaneous seizures was confirmed 6–8 hours a day, randomly.
+ Open protocol
+ Expand
7

Pilocarpine-Induced Seizure Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Scopolamine methylnitrate (Sigma; 1 mg/kg) was given 30 min subcutaneously before intraperitoneal (i.p.) injection of pilocarpine (Sigma; 0.177 mg/cm2). Additional half doses were administrated subcutaneously to rats that did not reach SE after the first injection, an hour after the first dose, and a third dose half an hour after the second injection. Four of the nine rats needed only one dose of pilocarpine, three needed two doses, and one received three doses. Four rats reached SE, i.e. continuous seizures, at Racine stage 529 (rats #1, 2, 6, 9) four at stage 4 (rats #3, 4, 5, 7), and one at stage 3 (rat #8).
Two hours after the onset of SE, diazepam (10 mg/kg i.p.; Roche) was given, followed by another dose of 5 mg/kg, given 1 h later subcutaneously.
There was no mortality due to SE.
+ Open protocol
+ Expand
8

Pilocarpine-Induced Status Epilepticus Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Induction of SE was performed as described previously 8 (link). Briefly, subcutaneous injection of scopolamine methyl nitrate (1 mg/kg, Sigma-Aldrich, S2250, CA, USA) was used to reduce the peripheral cholinergic effects of the pilocarpine. After 30 min, animals received an intraperitoneal injection of 290-320 mg/kg pilocarpine hydrochloride (Sigma-Aldrich, P6503, CA, USA) to induce SE. Seizures were terminated by a diazepam injection (10 mg/kg) 2 h after the onset of SE. The severity of convulsive responses was monitored by a video camera and classified according to the modified Racine scale 32 (link). Mice that showed consistent stage 4-5 seizures were used for SE-induced hippocampal inflammation experiments and those that did not show consistent acute seizure activity (stage 0-3) or developed severe tonic-clonic seizures were excluded from the study (these animals were euthanized to avoid pain and distress). Animals that did not receive pilocarpine hydrochloride injections served as the naïve control.
+ Open protocol
+ Expand
9

Pilocarpine-Induced Status Epilepticus in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mice were injected subcutaneously with 335 mg/kg pilocarpine hydrochloride (Sigma) to induce status epilepticus, 20 minutes after pre-treatment with subcutaneous injection of 1 mg/kg scopolamine methyl nitrate (Sigma).22 (link),23 (link) Animals received an injection of diazepam (4 mg/kg, s.c.; Ratiopharm) forty minutes after SE onset. Control animals were treated identically but received saline instead of pilocarpine (mock treated). Behavioural SE was clearly identified using a modified seizure scheme: sustained convulsions with postural loss designated as SE.22 (link),23 (link) Among pilocarpine injected animals, only those that developed SE (SE-experienced) were further used for analysis.
+ Open protocol
+ Expand
10

Anticonvulsant Activity of Vitamin C

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vitamin C, PTZ, scopolamine methyl nitrate, diethyl ether, pilocarpine hydrochloride, sodium valproate, Biuret reagent, acetylcholine iodide, 5′5-dithiobis-(2-nitrobenzoic acid) (DNTB), adrenaline, acetic acid, dichromate, hydrogen peroxide (H2O2), Tris-Hcl, trichloroacetic acid, thiobarbituric acid, sodium phosphate buffer, Griess reagent were purchased from Sigma Chemical Co., St. Louis (United States), while diazepam was purchased from Roche, Neuilly sur-Seine, France. The minimal dose of chemoconvulsant at which 99% of the animals showed a convulsion was determined based on the doses used by other researchers and by a dose-percentage effect curve (Miller and Tainter, 1944 (link); Ahmadiani et al., 2003 (link)). Vitamin C and sodium valproate were dissolved in distilled water. All solutions were prepared freshly in the day of the experiment and were administered intraperitoneally at a volume of 10 ml/kg, except for distilled water and aqueous extract of P. daemia administered per os at the same volume.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!